Risk assessment with gut microbiome and metabolite markers in NAFLD development

Leung, H; Long, XX; Ni, YQ; Qian, LL; Nychas, E; Siliceo, SL; Pohl, D; Hanhineva, K; Liu, Y; Xu, AM; Nielsen, HB; Belda, E; Clement, K; Loomba, R; Li, HT; Jia, WP; Panagiotou, G

Ni, YQ; Panagiotou, G (通讯作者),Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Syst Biol & Bioinformat Unit, Beutenbergstr 11A, D-07745 Jena, Germany.;Ni, YQ; Li, HT; Jia, WP (通讯作者),Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Dept Endocrinol & Metab, Shanghai Key Lab Diabet Mellitus,Shanghai Clin Ct, Shanghai 200233, Peoples R China.;Panagiotou, G (通讯作者),Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong, Peoples R China.;Panagiotou, G (通讯作者),Uni

SCIENCE TRANSLATIONAL MEDICINE, 2022; 14 (648):

Abstract

A growing body of evidence suggests interplay between the gut microbiota and the pathogenesis of nonalcoholic fatty liver disease (NAFLD). However, th......

Full Text Link